HUNTINGTON BEACH, Calif.--(BUSINESS WIRE)--Medical Devices & Diagnostics (MD&D) companies know they are being impacted by the current pandemic and are seeking independent research to quantify how much their markets will decline or increase, how long the recovery will take, and what factors will determine that recovery.
Covid-19 Impact Tracker data released. Orthopedic/Spine & Cardiovascular segments hit hard. Infection Control and Drug Delivery segments get huge boost. Most markets will rebound in 2021 but at varying paces. New data released every Monday at 7am PT.
A new surveillance tool to track the Impact of COVID-19 on medical devices & diagnostics markets is now available through research firm Life Science Intelligence (LSI).
According to LSI CEO Scott Pantel, “We’ve had an overwhelming number of clients -- from both the medtech and financial services communities -- come to us asking for guidance on how their markets are going to be impacted. Everyone is generally asking the same questions: How will medtech markets be impacted in the short-term and when will they rebound? How can we protect vulnerable business units and leverage opportunities in others? Which surgical procedures are being postponed, when will they bounce back, and how fast, so we can be ready?” Pantel adds that “LSI has been covering medtech markets for over 2 decades and we’ve been through crises like these before, 2018 as an example, but this situation is much more complicated with so many moving parts. Because of this, we’ve rolled out a new tracking tool to support our customers and their strategic decisions as best we can during these uncertain times.”
The new tool provides logical and thoroughly-researched forecasts. Details are available at: https://www.lifesciencemarketresearch.com/covid-19-impact-tracker
Early research from LSI indicates that the largest medical device & diagnostic companies will see varying levels of exposure.
High Exposure
- Medtronic
- J&J
- Stryker
- Boston Scientific
- Zimmer Biomet
- Olympus
- Smith & Nephew
Moderate Exposure
- Abbott
- Siemens Healthineers
- GE Healthcare
- Philips Health Care
- Roche Diagnostics
- Danaher
- B. Braun
- Terumo
Low Exposure
- Becton Dickinson
- Baxter
- Fresenius
- Cardinal Health
The full report examines:
- Surgical caseloads by major type (emergent, non-emergent, elective)
- 30+ technology markets by major type
- Markets by major geography
- Clinical markets by major type
About Life Science Intelligence (LSI) and Health Research International (HRI)
LSI and HRI have been tracking and forecasting Global MD&D Markets for 3 decades and are sought after by leading medical device, diagnostic and financial services firms for an independent and realistic assessment of market sizes and trends across the major medical technology segments. These research firms are strategic partners and collaborate on research projects and industry reports. HRI is a boutique market research and custom consulting firm with more than 40 years of experience analyzing and forecasting the full array medical devices & diagnostics markets. LSI is a medical technology market intelligence & consulting company with over 25 years of experience. Together LSI & HRI help medtech executives make informed strategic decisions faster.
